The Brudno lab harnesses biomaterials to manufacture and deliver cellular immunotherapies to improve patient outcome and quality of life. Projects focus on streamlining the production and administration of therapies, enhancing therapeutic efficacy in solid tumors, and treating autoimmune diseases.
